Clicky

Omega Diagnostics Group Plc(ODX)

Description: Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.


Keywords: Medicine Disease Gas Immunology Immune System Tumor Inflammation Quality Rheumatoid Arthritis Allergy Arthritis Radio Anemia Glycoproteins Medical Diagnostic Thyroid Hormones Immunoassay Assay Systemic Lupus Erythematosus Lupus Renal Disease Infectious Immunoglobulin E Vasculitis Connective Tissue Disease

Home Page: www.omegadiagnostics.com

ODX Technical Analysis

Omega House
Alva, FK12 5DQ
United Kingdom
Phone: 44 1259 763030


Officers

Name Title
Mr. Jagdeep Grewal B.Sc., M.B.A., M.Sc. CEO & Exec. Director
Mr. Christopher Paul Lea A.C.A., B.Sc. CFO, Company Sec. & Director
Mr. Iain Logan Group Financial Controller
Mr. Prashant Maniar Managing Director of Omega Dx Asia Pvt Limited
Mr. Andrew William Shepherd Global Ambassador - Life Pres

Exchange: LSE

Country: UK : United Kingdom

Currency: Pence sterling (p)

Forward PE: 33.0033
Trailing PE: 0
Price-to-Book MRQ: 0.6646
Price-to-Sales TTM: 1.1571
IPO Date: 2004-03-18
Fiscal Year End: March
Full Time Employees: 85
Back to stocks